SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?


To: pocotrader who wrote (1303723)6/12/2021 9:21:07 PM
From: Winfastorlose1 Recommendation

Recommended By
FJB

  Read Replies (2) | Respond to of 1573824
 
I know 10 times more science than you That is the problem taco. You believe in pseudo science. Over 10,000 real scientists have come out against the experimental fake vaccines. You listen to Crybaby and his politicians, not scientists.



To: pocotrader who wrote (1303723)6/12/2021 9:33:16 PM
From: Heywood401 Recommendation

Recommended By
pocotrader

  Respond to of 1573824
 
It's been amusing to watch him lose oh-so-slowly-and-deliciously since November 3.

He's been crying here every day now for 7+ months, and shows no sign of improvement.

HILARIOUS!!!



To: pocotrader who wrote (1303723)6/12/2021 10:04:37 PM
From: Winfastorlose2 Recommendations

Recommended By
FJB
isopatch

  Respond to of 1573824
 
Since you do not believe Dr Yeadon, the former Chief Science Officer at Pfizer when he says the vaccines are dangerous, let's see what the INVENTOR of mRNA vaccines has to say about it.

Dr Robert W Malone invented mRNA vaccines while working at the Salk Institute.

This is what he says. (he is surprised they allowed the use of the vaccines with no safety testing on humans)

TrialSite News contacted Dr. Robert W. Malone, the original inventor of mRNA vaccine technology and a senior regulatory specialist who serves as president of a prestigious European association who wished to remain anonymous.

When asked to review and comment on the EMA assessment, Malone noted normal pharmacokinetic and pharmaco-toxicology studies had not been performed before EUA authorization for the product.

“I was particularly surprised that the dossier of regulatory documents indicates allowance for use in humans based on non-GLP PK and Tox studies relying on formulations which are significantly different from the final vaccine,“ Malone said.

After completing a review, TrialSite’s other source noted the following:

“A quick review the Toxicology Section (2.3.3) of the European Medicines Agency (EMA) Assessment Report on Comirnaty (COVID-19 mRNA vaccine) issued on 19 February 2021, raises concerns about data applicability of preclinical study findings to clinical use:

“To determine the biodistribution of the LNP-formulated modified mRNA (modRNA), the applicant did study distribution of the modRNA in two different non-GLP studies, in mice and rats, and determined the biodistribution of a surrogate luciferase modRNA.

“Thus, one might question the validity and applicability of non-GLP studies conducted using a variant of the subject mRNA vaccine.

“In addition, no genotoxicity data were provided to EMA.”

According to official government accounts, minimal risk is associated with COVID vaccines when compared to the risks of COVID infection. This belief forms the basis of the U.S. Food and Drug Administration’s Emergency Use Authorization approval, which is based on a risk-benefit analysis.

However, a search in the Centers for Disease Control and Prevention’s Vaccine Adverse Events Reporting System (VAERS) revealed 294,801 reports of adverse events following COVID vaccines, including 5,165 deaths and 25,359 serious injuries between Dec. 14, 2020 and May 28, 2021.

Though the U.S. government argues none of the deaths have been formally linked to COVID vaccines and the reported adverse event risk is low, the discovery of these documents and associated information may alter the risk-benefit assessment underlying the EUA decision, TrialSite News reported.

As The Defender and TrialSite News reported, documents obtained by scientists through the Freedom of Information Act (FOIA) revealed pre-clinical studies showing the active part of the vaccine (mRNA-lipid nanoparticles) — which produce the spike protein — did not stay at the injection site and surrounding lymphoid tissue as scientists originally theorized, but spread widely throughout the body and accumulated in various organs, including the ovaries and spleen.



To: pocotrader who wrote (1303723)6/12/2021 10:14:29 PM
From: Winfastorlose2 Recommendations

Recommended By
FJB
isopatch

  Respond to of 1573824
 
Pfizer Skipped Critical Testing and Cut Corners on Quality Standards, Documents Reveal




To: pocotrader who wrote (1303723)6/12/2021 11:49:31 PM
From: Winfastorlose1 Recommendation

Recommended By
FJB

  Respond to of 1573824